U.S. Absorbable Surgical Sutures Market Research Report By Application (Cardiothoracic Surgery, Orthopedic Surgery, General Surgery, Gynecological Surgery, Plastic Surgery), By Material (Polyglycolic Acid, Polylactic Acid, Catgut, Polycaprolactone, Chitosan), By Suture Type (Monofilament Sutures, Multifilament Sutures, Braided Sutures) and By End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics) - Growth & Industry Forecast 2025 To 2035.
As per Market Research Future analysis, the US absorbable surgical sutures market size was estimated at 898.8 USD Million in 2024. The US absorbable surgical-sutures market is projected to grow from 936.46 USD Million in 2025 to 1411.72 USD Million by 2035, exhibiting a compound annual growth rate (CAGR) of 4.1% during the forecast period 2025 - 2035
The US absorbable surgical-sutures market is poised for growth driven by technological advancements and increasing demand for minimally invasive procedures.
| 2024 Market Size | 898.8 (USD Million) |
| 2035 Market Size | 1411.72 (USD Million) |
| CAGR (2025 - 2035) | 4.19% |
Ethicon (US), Medtronic (US), B. Braun Melsungen AG (DE), Sutures India (IN), Smith & Nephew (GB), Mölnlycke Health Care (SE), Surgical Specialties Corporation (CA), DemeTECH Corporation (US)
Our Impact
Enabled $4.3B Revenue Impact for Fortune 500 and Leading Multinationals
Partnering with 2000+ Global Organizations Each Year
30K+ Citations by Top-Tier Firms in the Industry
The absorbable surgical-sutures market is currently experiencing notable growth, driven by advancements in medical technology and an increasing preference for minimally invasive surgical procedures. Surgeons and healthcare providers are increasingly opting for absorbable sutures due to their ability to eliminate the need for suture removal, thereby enhancing patient comfort and reducing the risk of infection. This trend aligns with the broader movement towards patient-centered care, where the focus is on improving outcomes and streamlining recovery processes. Furthermore, the rise in surgical procedures across various specialties, including orthopedics, gynecology, and general surgery, is contributing to the heightened demand for these sutures. In addition, the regulatory landscape surrounding absorbable surgical sutures is evolving, with agencies emphasizing safety and efficacy. This regulatory scrutiny is likely to foster innovation, as manufacturers strive to meet stringent standards while developing new materials and technologies. The market appears poised for further expansion, as ongoing research and development efforts yield novel products that cater to diverse surgical needs. As healthcare systems continue to prioritize cost-effective solutions, absorbable sutures may play a pivotal role in enhancing surgical practices and improving patient outcomes.
Recent innovations in materials and manufacturing processes are enhancing the performance of absorbable surgical sutures. Newer polymers and coatings are being developed to improve biocompatibility and reduce inflammatory responses, which may lead to better healing outcomes.
There is a growing trend towards minimally invasive surgeries, which often utilize absorbable sutures. This shift is driven by patient preferences for reduced recovery times and lower complication rates, indicating a potential increase in the use of these sutures.
The regulatory environment for absorbable surgical sutures is becoming more stringent, with agencies focusing on safety and efficacy. This may encourage manufacturers to invest in research and development, leading to the introduction of advanced products that meet evolving standards.
The increasing geriatric population in the US is a significant driver for the absorbable surgical-sutures market. As individuals age, they often require more surgical interventions due to various health issues, including cardiovascular diseases and orthopedic conditions. The US Census Bureau projects that by 2030, approximately 20% of the population will be aged 65 and older, leading to a higher demand for surgical procedures. Absorbable sutures are particularly advantageous for older patients, as they reduce the risk of complications associated with suture removal. The absorbable surgical-sutures market is likely to expand in response to this demographic shift, as healthcare providers seek effective solutions to cater to the needs of an aging population.
The rise in the number of surgical procedures in the US is a primary driver for the absorbable surgical-sutures market. As healthcare facilities expand their capabilities, the demand for effective suturing solutions grows. In 2025, the American College of Surgeons reported an increase in elective surgeries, which has led to a heightened need for absorbable sutures. These sutures are preferred for their ability to dissolve over time, reducing the need for suture removal. The absorbable surgical-sutures market is likely to benefit from this trend, as surgeons increasingly opt for materials that enhance patient recovery and minimize complications. Furthermore, advancements in surgical techniques and technologies are expected to further propel the market, as they often require specialized suturing materials that absorbable options provide.
Patient safety has become a focal point in the US healthcare system, influencing the absorbable surgical-sutures market. The emphasis on reducing post-operative complications and improving recovery times has led to a preference for absorbable sutures. These sutures minimize the risk of infection and eliminate the need for additional procedures to remove non-absorbable sutures. According to the American Medical Association, the adoption of absorbable sutures has increased by approximately 15% in recent years, reflecting a shift towards safer surgical practices. The absorbable surgical-sutures market is likely to see continued growth as healthcare providers prioritize patient outcomes and safety, aligning with broader trends in healthcare quality improvement.
The expansion of healthcare infrastructure in the US is driving growth in the absorbable surgical-sutures market. As new hospitals and surgical centers are established, there is an increased demand for surgical supplies, including absorbable sutures. The US Department of Health and Human Services has reported significant investments in healthcare facilities, which are expected to enhance surgical capabilities. This expansion is likely to lead to a higher volume of surgeries performed, thereby increasing the consumption of absorbable sutures. The absorbable surgical-sutures market stands to benefit from this trend, as healthcare providers seek reliable and effective suturing options to support their growing surgical operations.
Technological advancements in the development of suturing materials are significantly impacting the absorbable surgical-sutures market. Innovations such as the introduction of new polymers and coatings enhance the performance of absorbable sutures, making them more effective in various surgical applications. For instance, recent developments have led to sutures that offer improved tensile strength and controlled absorption rates, catering to diverse surgical needs. The absorbable surgical-sutures market is poised for growth as manufacturers invest in research and development to create superior products. This focus on innovation not only meets the evolving demands of surgeons but also aligns with the increasing expectations of patients for high-quality surgical outcomes.
In the US absorbable surgical-sutures market, synthetic sutures dominate with a significant share, benefiting from their widespread use in various surgical procedures due to their predictable absorption rates and strength. These sutures are favored in countless applications including cardiovascular and orthopedic surgeries. In contrast, natural sutures, while currently holding a smaller market share, are gaining traction due to their biodegradable properties and reduced tissue reactivity, appealing to a segment of surgeons focused on innovative and effective surgical practices. Growth trends indicate a robust increase in the adoption of natural sutures, driven by a growing preference for biocompatible materials among healthcare providers and patients alike. As the healthcare sector increasingly leans toward less invasive treatments and materials that promote healing without adverse effects, natural sutures are poised for rapid expansion. Synthetic sutures are expected to maintain their lead in market share due to ongoing advancements in material technology that enhance performance and versatility.
Sutures: Synthetic (Dominant) vs. Natural (Emerging)
Synthetic sutures are recognized as the dominant force in the US absorbable surgical-sutures market, attributed to their reliability, durability, and favorable absorption characteristics. They are typically made from polymers such as polyglycolic acid and polylactic acid, which provide consistent tensile strength and predictable absorption timelines, making them ideal for a variety of surgical applications, particularly in challenging environments. On the other hand, natural sutures, emerging as a preferred alternative, are made from organic materials like collagen or gut, which enhance biocompatibility and promote natural healing. The shift towards natural sutures is stimulated by their lower tissue reactivity and environmental sustainability, signaling a broader trend towards green healthcare solutions.
In the US absorbable surgical-sutures market, monofilament sutures account for a significant share, reflecting their preference among surgeons for various procedures. These sutures are known for their strength and minimal tissue trauma, leading to a sizeable competitive edge over multifilament options. Conversely, multifilament sutures have been emerging rapidly due to their superior flexibility and ease of handling, making them increasingly popular in complex surgical applications. The growing trend toward minimally invasive surgeries and advancements in suture materials are driving their adoption, indicating a promising growth trajectory.
Monofilament (Dominant) vs. Multifilament (Emerging)
Monofilament sutures, characterized by a single strand, dominate the market owing to their enhanced tensile strength and reduced risk of infection. They are ideal for a range of procedures, particularly those that require precision and minimal tissue irritation. On the other hand, multifilament sutures, composed of multiple strands, are gaining traction for their excellent knot security and flexibility, which make them suitable for diverse surgical applications. The increasing demand for complex surgical techniques has bolstered the market presence of multifilament sutures, positioning them as a compelling alternative in the evolving landscape of surgical practices.
The US absorbable surgical-sutures market exhibits a diverse application segment, prominently featuring general surgeries, which command the largest share due to their widespread use in various medical procedures. Following closely are cardiovascular surgeries, showing rapid growth attributed to the increasing prevalence of heart diseases and advancements in surgical techniques that favor absorbable sutures for better tissue integration and patient recovery. Additionally, orthopedic surgeries and gynecological surgeries constitute substantial portions of the market, highlighting the versatile applications of absorbable sutures across different surgical fields. Growth trends within the application segment of the US absorbable surgical-sutures market are driven by technological innovations and an increasing emphasis on patient-centered care. As surgical procedures become more complex, the demand for effective and reliable suturing solutions like absorbable sutures rises. The rising geriatric population, coupled with a growing number of surgical interventions, further supports this trend. The continuous development of new suture materials and designs is also expected to enhance functionality and patient outcomes, fueling market expansion in the coming years.
General Surgeries: Dominant vs. Cardiovascular Surgeries: Emerging
In the application segment of the US absorbable surgical-sutures market, general surgeries stand out as the dominant force due to their extensive range of procedures, from minor to major interventions. These surgeries frequently utilize absorbable sutures for their benefits, such as reduced risk of infections and the elimination of the need for suture removal. On the other hand, cardiovascular surgeries are recognized as an emerging segment, rapidly gaining traction due to the rising incidences of cardiac ailments and the advancements in minimally invasive surgical techniques. This growth reflects a shift towards innovative solutions that absorbable sutures provide, making them increasingly preferred among surgeons for suturing delicate tissues in the cardiovascular space.
The market share distribution among the end-users in the US absorbable surgical-sutures market is notably diverse. Hospitals hold the largest share due to their extensive surgical needs and higher patient volume, facilitating the demand for absorbable sutures. In contrast, clinics are emerging as a significant player, capturing a noteworthy percentage of the market as they expand their services and surgical capabilities. Ambulatory surgery centers and other segments also contribute to overall dynamics but lag behind hospitals and clinics in market share. Growth trends within this segment indicate a strong incline towards the use of absorbable sutures, driven by the rising number of surgeries performed in hospitals and clinics. Factors such as technological advancements in suture materials, increased emphasis on patient recovery, and a preference for minimally invasive surgical procedures are propelling the market forward. As clinics enhance their surgical offerings and ambulatory surgery centers revolutionize outpatient procedures, the competitive landscape is rapidly evolving, highlighting the importance of adaptability in surgical solutions.
Hospitals: Dominant vs. Clinics: Emerging
Hospitals represent the dominant force in the end-users segment of the US absorbable surgical-sutures market, facilitated by their robust infrastructure and larger scale of operations. Their surgical units often necessitate a consistent supply of high-quality absorbable sutures, making them key customers for manufacturers. On the other hand, clinics are emerging as a significant contributor to market growth, adapting quickly to the trends favoring outpatient surgeries. They are increasingly adopting absorbable sutures to improve patient satisfaction and minimize recovery time. This shift is supported by the growing number of surgical procedures being performed in outpatient settings, showcasing the adaptability and expanding market potential of clinics as they continue to evolve in the surgical landscape.
Get more detailed insights about US Absorbable Surgical Sutures Market Request Free Sample
The absorbable surgical-sutures market exhibits a dynamic competitive landscape characterized by innovation and strategic partnerships. Key players such as Ethicon (US), Medtronic (US), and B. Braun Melsungen AG (DE) are at the forefront, leveraging their extensive research and development capabilities to enhance product offerings. Ethicon (US) focuses on advancing its suture technology, particularly in bioresorbable materials, which aligns with the growing demand for minimally invasive surgical solutions. Medtronic (US) emphasizes digital transformation, integrating advanced data analytics into its product development processes, thereby enhancing operational efficiency and patient outcomes. B. Braun Melsungen AG (DE) adopts a strategy of regional expansion, particularly in emerging markets, to capture a larger share of the growing demand for absorbable sutures. Collectively, these strategies foster a competitive environment that prioritizes innovation and responsiveness to market needs.The market structure appears moderately fragmented, with several players vying for market share through localized manufacturing and optimized supply chains. Companies are increasingly localizing production to reduce lead times and enhance responsiveness to regional demands. This tactic not only mitigates supply chain disruptions but also aligns with sustainability goals, as local manufacturing often reduces carbon footprints. The collective influence of these key players shapes a competitive landscape where agility and innovation are paramount.
In September Ethicon (US) announced the launch of its new line of absorbable sutures designed with enhanced tensile strength and reduced tissue reactivity. This strategic move is significant as it addresses the growing demand for sutures that minimize postoperative complications, thereby potentially increasing market share in the surgical sector. The introduction of these advanced sutures reflects Ethicon's commitment to innovation and its proactive approach to meeting evolving surgical needs.
In October Medtronic (US) unveiled a partnership with a leading AI technology firm to develop smart sutures that can monitor healing processes in real-time. This collaboration signifies a pivotal shift towards integrating technology into surgical practices, potentially revolutionizing postoperative care. By harnessing AI, Medtronic aims to enhance patient outcomes and streamline surgical workflows, positioning itself as a leader in the digital transformation of surgical solutions.
In August B. Braun Melsungen AG (DE) expanded its manufacturing capabilities in North America, investing €50 million in a new facility dedicated to producing absorbable sutures. This expansion is indicative of the company's strategy to bolster its presence in the lucrative North American market, responding to increasing demand for high-quality surgical products. Such investments not only enhance production capacity but also signify a long-term commitment to meeting the needs of healthcare providers in the region.
As of November current trends in the absorbable surgical-sutures market are increasingly defined by digitalization, sustainability, and the integration of AI technologies. Strategic alliances are becoming more prevalent, as companies recognize the value of collaboration in driving innovation. The competitive differentiation is likely to evolve from traditional price-based competition towards a focus on technological advancements, product innovation, and supply chain reliability. This shift underscores the importance of adaptability and foresight in navigating the complexities of the modern healthcare landscape.
The US Absorbable Surgical Sutures Market is currently witnessing several developments, particularly concerning notable companies like Ethicon, Medtronic, and B. Braun. In recent months, market valuation for these companies has been positively influenced by a growing demand for minimally invasive surgical procedures. In June 2023, Ethicon launched its latest absorbable sutures, integrating advanced biomaterials that enhance wound healing and tissue regeneration, reflecting a trend toward innovation in surgical products. Additionally, in August 2023, Medtronic announced a collaboration with a biotech firm to develop next-generation suturing devices aimed at improving surgical precision and patient outcomes. Notably, in September 2023, B.
Braun acquired a small firm specializing in biodegradable sutures, which is expected to strengthen its product portfolio.
The overall market continues to expand, driven by advancements in technology and increased surgical procedures, particularly as healthcare systems adapt post-pandemic. Over the last few years, there has been a significant shift towards biocompatible materials in sutures, with many companies focusing on research and development to satisfy the increasing demand for effective and safe surgical solutions.
The Absorbable Surgical Sutures Market is projected to grow at a 4.19% CAGR from 2025 to 2035, driven by technological advancements and increasing surgical procedures.
New opportunities lie in:
By 2035, the market is expected to achieve robust growth and innovation.
| MARKET SIZE 2024 | 898.8(USD Million) |
| MARKET SIZE 2025 | 936.46(USD Million) |
| MARKET SIZE 2035 | 1411.72(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 4.19% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | Ethicon (US), Medtronic (US), B. Braun Melsungen AG (DE), Sutures India (IN), Smith & Nephew (GB), Mölnlycke Health Care (SE), Surgical Specialties Corporation (CA), DemeTECH Corporation (US) |
| Segments Covered | Type, Structure, Application, End-Users |
| Key Market Opportunities | Advancements in biocompatible materials enhance performance in the absorbable surgical-sutures market. |
| Key Market Dynamics | Technological advancements and regulatory changes drive innovation in the absorbable surgical-sutures market. |
| Countries Covered | US |
The market valuation was $898.8 Million in 2024.
The projected valuation for 2035 is $1411.72 Million.
The expected CAGR during this period is 4.19%.
Key players include Ethicon, Medtronic, B. Braun Melsungen AG, Sutures India, Smith & Nephew, Mölnlycke Health Care, Surgical Specialties Corporation, and DemeTECH Corporation.
The two main types are synthetic sutures, valued at $650.0 Million, and natural sutures, valued at $761.72 Million.
The market is segmented into monofilament sutures, valued at $650.0 Million, and multifilament sutures, valued at $761.72 Million.
General surgeries, valued at $320.0 Million, and orthopedic surgeries, valued at $280.0 Million, dominate the market.
Hospitals are the largest consumers, with a valuation of $550.0 Million, followed by clinics at $400.0 Million.
The market is expected to grow steadily, reaching $1411.72 Million by 2035.
The market is anticipated to increase from $898.8 Million in 2024 to $1411.72 Million in 2035.
Kindly complete the form below to receive a free sample of this Report
“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”
“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”
“Thanks for sending the report it gives us a good global view of the Betaïne market.”
“Thank you, this will be very helpful for OQS.”
“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”
“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”
“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”
“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”
“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”
